SIGLEC5

Gene Facts

• HGNC Symbol: SIGLEC5 (HGNC:10874)
• HGNC Name: sialic acid binding Ig like lectin 5
• Gene type: protein-coding gene
• Locus type: gene with protein product
• Previous symbols: CD33L2
• Alias symbols: OB-BP2, SIGLEC-5, CD170
• %HI: 97.84
• pLI: 0
• LOEUF: 1.16
• Cytoband: 19q13.41
• Genomic Coordinates:

  GRCh37/hg19:	chr19:52114213-52133654
  GRCh38/hg38:	chr19:51610960-51630401

• MANE Select Transcript: NM_003830.4 ENST00000683636.1
• Function: Putative adhesion molecule that mediates sialic-acid dependent binding to cells. Binds equally to alpha-2,3-linked and alpha-2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface. (Source: Uniprot)

Dosage Sensitivity Summary (Gene)

• Dosage ID: ISCA-29456
• ClinGen Curation ID: CCID:007848
• Curation Status: Complete
• Issue Type: Dosage Curation - Gene
• Haploinsufficiency: Dosage Sensitivity Unlikely (40)
• Triplosensitivity: No Evidence for Triplosensitivity (0)
• Last Evaluated: 02/02/2021

Haploinsufficiency (HI) Score Details

• HI Score: 40
• HI Evidence Strength: Dosage Sensitivity Unlikely

HI Evidence

• PUBMED: 32487729
  Rausell et al. (2020) suggested that this gene is dosage sensitivity unlikely because it had at least one homozygous LoF variant present in >1% of the gnomAD population. Examples of homozygous likely LoF variants in this gene in gnomAD include p.Arg356Ter (280 homozygous individuals), p.Arg303Ter (1 homozygous individual), and p.Ala277CysfsTer71 (5 homozygous individuals).
• PUBMED: 28406212
  Saleheen et al. (2017) identified one adult individual in a Pakistani population with a homozygous LoF variant in this gene. The individuals were originally recruited for a study evaluating risk of myocardial infarction. Individuals within that study found to have homozygous predicted LOF variants were phenotyped for “more than 200 biochemical and disease traits”.
• PUBMED: 25807282
  Sulem et al. (2015) identified 4 individuals in an Icelandic population with a homozygous LoF variant in this gene. This population was participating in a variety of disease projects and the researchers pulled this population to investigate how often homozygous LoF variants were found in this population.
• PUBMED: 26940866
  Narasimhan et al. (2016) identified rare homozygous loss-of-function (rnLOF) variants in a British Pakistani population characterized as healthy, pregnant, or type 2 diabetic. The variants were compared with an Icelandic population and the ExAC database and a SIGLEC5 variant was found in the British Pakistani, Icelandic and ExAC populations.
• PUBMED: 32461654
  Karczewski et al. (2020) identifies 443,769 high confidence loss of function variants in the Genome Aggregation Database (gnomAD) population including these likely LoF variants (p.Arg356Ter, p.Arg303Ter, and p.Ala277CysfsTer71). Several methods were used to identify these genes including manual curation and utilizing LOEUF scores.

• HI Evidence Comments: This gene was classified as dosage sensitivity unlikely on 2/2/2021 based on review of population data as described in the PMIDs above. These genes all have at least one curated homozygous loss of function variant in 1% or greater of the gnomAD population dataset and some have also been observed in additional population datasets. As of January 2021, there are no disease associations found in OMIM, and no reports suggesting a Mendelian disease association in the literature. The gnomAD pLI score is 0 and the LOEUF score is 0.98 predicting that this gene is tolerant of LoF variation.

Triplosensitivity (TS) Score Details

• TS Score: 0
• TS Evidence Strength: No Evidence for Triplosensitivity